Reprint of

Development of bioactive peptide amphiphiles for therapeutic cell delivery

Matthew J. Webber, Jörn Tongers, Marie Ange Renault, Jerome G. Roncalli, Douglas W. Losordo, Samuel I Stupp

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

There is great clinical interest in cell-based therapies for ischemic tissue repair in cardiovascular disease. However, the regenerative potential of these therapies is limited due to poor cell viability and minimal retention following application. We report here the development of bioactive peptide amphiphile nanofibers displaying the fibronectin-derived RGDS cell adhesion epitope as a scaffold for therapeutic delivery of bone marrow derived stem and progenitor cells. When grown on flat substrates, a binary peptide amphiphile system consisting of 10 wt.% RGDS-containing molecules and 90 wt.% negatively charged diluent molecules was found to promote optimal cell adhesion. This binary system enhanced adhesion 1.4-fold relative to substrates composed of only the non-bioactive diluent. Additionally, no enhancement was found upon scrambling the epitope and adhesion was no longer enhanced upon adding soluble RGDS to the cell media, indicating RGDS-specific adhesion. When encapsulated within self-assembled scaffolds of the binary RGDS nanofibers in vitro, cells were found to be viable and proliferative, increasing in number by 5.5 times after only 5 days, an effect again lost upon adding soluble RGDS. Cells encapsulated within a non-bioactive scaffold and those within a binary scaffold with scrambled epitope showed minimal viability and no proliferation. Cells encapsulated within this RGDS nanofiber gel also increase in endothelial character, evident by a decrease in the expression of CD34 paired with an increase in the expression of endothelial-specific markers VE-Cadherin, VEGFR2 and eNOS after 5 days. In an in vivo study, nanofibers and luciferase-expressing cells were co-injected subcutaneously in a mouse model. The binary RGDS material supported these cells in vivo, evident by a 3.2-fold increase in bioluminescent signal attributable to viable cells; this suggests the material has an anti-apoptotic and/or proliferative effect on the transplanted bone marrow cells. We conclude that the binary RGDS-presenting nanofibers developed here demonstrate enhanced viability, proliferation and adhesion of associated bone marrow derived stem and progenitor cells. This study suggests potential for this material as a scaffold to overcome current limitations of stem cell therapies for ischemic diseases.

Original languageEnglish
Pages (from-to)S42-S51
JournalActa Biomaterialia
Volume23
Issue numberS
DOIs
Publication statusPublished - Sep 1 2015

Fingerprint

Amphiphiles
Nanofibers
Peptides
Epitopes
Scaffolds
Adhesion
Stem Cells
Bone
Cell adhesion
Cells
Cell- and Tissue-Based Therapy
Cell Adhesion
Therapeutics
Molecules
Bone Marrow
Substrates
Scaffolds (biology)
Stem cells
Luciferases
Fibronectins

Keywords

  • Ischemic tissue disease
  • Peptide amphiphile
  • Regenerative medicine
  • RGDS
  • Therapeutic cell delivery

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Biotechnology
  • Biochemistry
  • Molecular Biology

Cite this

Reprint of : Development of bioactive peptide amphiphiles for therapeutic cell delivery. / Webber, Matthew J.; Tongers, Jörn; Renault, Marie Ange; Roncalli, Jerome G.; Losordo, Douglas W.; Stupp, Samuel I.

In: Acta Biomaterialia, Vol. 23, No. S, 01.09.2015, p. S42-S51.

Research output: Contribution to journalArticle

Webber, Matthew J. ; Tongers, Jörn ; Renault, Marie Ange ; Roncalli, Jerome G. ; Losordo, Douglas W. ; Stupp, Samuel I. / Reprint of : Development of bioactive peptide amphiphiles for therapeutic cell delivery. In: Acta Biomaterialia. 2015 ; Vol. 23, No. S. pp. S42-S51.
@article{88cd9c34ffd043d68a6fb0d59f204e5b,
title = "Reprint of: Development of bioactive peptide amphiphiles for therapeutic cell delivery",
abstract = "There is great clinical interest in cell-based therapies for ischemic tissue repair in cardiovascular disease. However, the regenerative potential of these therapies is limited due to poor cell viability and minimal retention following application. We report here the development of bioactive peptide amphiphile nanofibers displaying the fibronectin-derived RGDS cell adhesion epitope as a scaffold for therapeutic delivery of bone marrow derived stem and progenitor cells. When grown on flat substrates, a binary peptide amphiphile system consisting of 10 wt.{\%} RGDS-containing molecules and 90 wt.{\%} negatively charged diluent molecules was found to promote optimal cell adhesion. This binary system enhanced adhesion 1.4-fold relative to substrates composed of only the non-bioactive diluent. Additionally, no enhancement was found upon scrambling the epitope and adhesion was no longer enhanced upon adding soluble RGDS to the cell media, indicating RGDS-specific adhesion. When encapsulated within self-assembled scaffolds of the binary RGDS nanofibers in vitro, cells were found to be viable and proliferative, increasing in number by 5.5 times after only 5 days, an effect again lost upon adding soluble RGDS. Cells encapsulated within a non-bioactive scaffold and those within a binary scaffold with scrambled epitope showed minimal viability and no proliferation. Cells encapsulated within this RGDS nanofiber gel also increase in endothelial character, evident by a decrease in the expression of CD34 paired with an increase in the expression of endothelial-specific markers VE-Cadherin, VEGFR2 and eNOS after 5 days. In an in vivo study, nanofibers and luciferase-expressing cells were co-injected subcutaneously in a mouse model. The binary RGDS material supported these cells in vivo, evident by a 3.2-fold increase in bioluminescent signal attributable to viable cells; this suggests the material has an anti-apoptotic and/or proliferative effect on the transplanted bone marrow cells. We conclude that the binary RGDS-presenting nanofibers developed here demonstrate enhanced viability, proliferation and adhesion of associated bone marrow derived stem and progenitor cells. This study suggests potential for this material as a scaffold to overcome current limitations of stem cell therapies for ischemic diseases.",
keywords = "Ischemic tissue disease, Peptide amphiphile, Regenerative medicine, RGDS, Therapeutic cell delivery",
author = "Webber, {Matthew J.} and J{\"o}rn Tongers and Renault, {Marie Ange} and Roncalli, {Jerome G.} and Losordo, {Douglas W.} and Stupp, {Samuel I}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.actbio.2015.07.018",
language = "English",
volume = "23",
pages = "S42--S51",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",
number = "S",

}

TY - JOUR

T1 - Reprint of

T2 - Development of bioactive peptide amphiphiles for therapeutic cell delivery

AU - Webber, Matthew J.

AU - Tongers, Jörn

AU - Renault, Marie Ange

AU - Roncalli, Jerome G.

AU - Losordo, Douglas W.

AU - Stupp, Samuel I

PY - 2015/9/1

Y1 - 2015/9/1

N2 - There is great clinical interest in cell-based therapies for ischemic tissue repair in cardiovascular disease. However, the regenerative potential of these therapies is limited due to poor cell viability and minimal retention following application. We report here the development of bioactive peptide amphiphile nanofibers displaying the fibronectin-derived RGDS cell adhesion epitope as a scaffold for therapeutic delivery of bone marrow derived stem and progenitor cells. When grown on flat substrates, a binary peptide amphiphile system consisting of 10 wt.% RGDS-containing molecules and 90 wt.% negatively charged diluent molecules was found to promote optimal cell adhesion. This binary system enhanced adhesion 1.4-fold relative to substrates composed of only the non-bioactive diluent. Additionally, no enhancement was found upon scrambling the epitope and adhesion was no longer enhanced upon adding soluble RGDS to the cell media, indicating RGDS-specific adhesion. When encapsulated within self-assembled scaffolds of the binary RGDS nanofibers in vitro, cells were found to be viable and proliferative, increasing in number by 5.5 times after only 5 days, an effect again lost upon adding soluble RGDS. Cells encapsulated within a non-bioactive scaffold and those within a binary scaffold with scrambled epitope showed minimal viability and no proliferation. Cells encapsulated within this RGDS nanofiber gel also increase in endothelial character, evident by a decrease in the expression of CD34 paired with an increase in the expression of endothelial-specific markers VE-Cadherin, VEGFR2 and eNOS after 5 days. In an in vivo study, nanofibers and luciferase-expressing cells were co-injected subcutaneously in a mouse model. The binary RGDS material supported these cells in vivo, evident by a 3.2-fold increase in bioluminescent signal attributable to viable cells; this suggests the material has an anti-apoptotic and/or proliferative effect on the transplanted bone marrow cells. We conclude that the binary RGDS-presenting nanofibers developed here demonstrate enhanced viability, proliferation and adhesion of associated bone marrow derived stem and progenitor cells. This study suggests potential for this material as a scaffold to overcome current limitations of stem cell therapies for ischemic diseases.

AB - There is great clinical interest in cell-based therapies for ischemic tissue repair in cardiovascular disease. However, the regenerative potential of these therapies is limited due to poor cell viability and minimal retention following application. We report here the development of bioactive peptide amphiphile nanofibers displaying the fibronectin-derived RGDS cell adhesion epitope as a scaffold for therapeutic delivery of bone marrow derived stem and progenitor cells. When grown on flat substrates, a binary peptide amphiphile system consisting of 10 wt.% RGDS-containing molecules and 90 wt.% negatively charged diluent molecules was found to promote optimal cell adhesion. This binary system enhanced adhesion 1.4-fold relative to substrates composed of only the non-bioactive diluent. Additionally, no enhancement was found upon scrambling the epitope and adhesion was no longer enhanced upon adding soluble RGDS to the cell media, indicating RGDS-specific adhesion. When encapsulated within self-assembled scaffolds of the binary RGDS nanofibers in vitro, cells were found to be viable and proliferative, increasing in number by 5.5 times after only 5 days, an effect again lost upon adding soluble RGDS. Cells encapsulated within a non-bioactive scaffold and those within a binary scaffold with scrambled epitope showed minimal viability and no proliferation. Cells encapsulated within this RGDS nanofiber gel also increase in endothelial character, evident by a decrease in the expression of CD34 paired with an increase in the expression of endothelial-specific markers VE-Cadherin, VEGFR2 and eNOS after 5 days. In an in vivo study, nanofibers and luciferase-expressing cells were co-injected subcutaneously in a mouse model. The binary RGDS material supported these cells in vivo, evident by a 3.2-fold increase in bioluminescent signal attributable to viable cells; this suggests the material has an anti-apoptotic and/or proliferative effect on the transplanted bone marrow cells. We conclude that the binary RGDS-presenting nanofibers developed here demonstrate enhanced viability, proliferation and adhesion of associated bone marrow derived stem and progenitor cells. This study suggests potential for this material as a scaffold to overcome current limitations of stem cell therapies for ischemic diseases.

KW - Ischemic tissue disease

KW - Peptide amphiphile

KW - Regenerative medicine

KW - RGDS

KW - Therapeutic cell delivery

UR - http://www.scopus.com/inward/record.url?scp=84938309660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938309660&partnerID=8YFLogxK

U2 - 10.1016/j.actbio.2015.07.018

DO - 10.1016/j.actbio.2015.07.018

M3 - Article

VL - 23

SP - S42-S51

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

IS - S

ER -